• Cholesterol Impedes Intracellular Trafficking of Lipid Nanop

  2026-04-12

  This study reveals that elevated cholesterol content in lipid nanoparticles (LNPs) significantly hinders their intracellular trafficking by promoting aggregation in peripheral endosomes, reducing nucleic acid delivery efficiency. These findings refine our understanding of LNP component optimization for gene delivery and highlight the importance of cholesterol balance in LNP formulation.

• Optimizing Cell Assays with ω-Agatoxin IVA TFA (SKU C8722)

  2026-04-12

  This article addresses real laboratory challenges in cell viability, synaptic transmission, and neuroprotection assays by providing scenario-driven, evidence-based guidance on using ω-Agatoxin IVA TFA (SKU C8722). It demonstrates how this highly selective Cav2.1 channel blocker from APExBIO delivers reproducible, quantitative results for neuroscience and epilepsy research workflows.

• Myriocin as a Serine Palmitoyltransferase Inhibitor: Applied

  2026-04-11

  Myriocin accelerates sphingolipid metabolism research by delivering potent, selective inhibition of serine palmitoyltransferase, facilitating breakthroughs in metabolic, cancer, and immunology models. This guide details workflow design, troubleshooting, and new translational insights, bridging bench performance with real-world impact.

• MDL 28170: Calpain Inhibitor for Neuroprotection & Assay Pre

  2026-04-11

  MDL 28170 enables reproducible, high-sensitivity inhibition of calpain and cathepsin B in both neuroprotection and cell death assays, with proven blood-brain barrier permeability. This compound’s validated efficacy in ischemia, neurodevelopment, and infection models makes it a cornerstone for translational research and troubleshooting complex workflows.

• Nebivolol Hydrochloride: Precision β1-Adrenoceptor Antago...

  2026-04-10

  Nebivolol hydrochloride stands out as a highly selective β1-adrenergic receptor inhibitor, enabling precise modulation of cardiac signaling pathways in cardiovascular pharmacology research. This guide details optimal experimental workflows, advanced use-cases, and troubleshooting strategies, with a focus on leveraging Nebivolol hydrochloride's purity, solubility, and specificity for reproducible, high-impact results.

• 5-Methyl-CTP: Modified Nucleotide for Enhanced mRNA Synth...

  2026-04-09

  Unlock the full potential of mRNA synthesis with 5-Methyl-CTP—a modified cytidine triphosphate that dramatically enhances mRNA stability and translation efficiency. This advanced nucleotide from APExBIO empowers gene expression research, mRNA vaccine development, and next-generation therapeutics with robust, reproducible results.

• LY2886721 (SKU A8465): Precision BACE1 Inhibition for Rob...

  2026-04-08

  This article explores how LY2886721 (SKU A8465), a potent oral BACE1 inhibitor from APExBIO, addresses common laboratory challenges in amyloid beta pathway research. Scenario-driven Q&A blocks provide evidence-based guidance on assay design, synaptic safety, biomarker interpretation, protocol optimization, and vendor reliability—helping researchers achieve reproducible, high-fidelity data in neurodegenerative disease models.

• Streptavidin–FITC: High-Affinity Fluorescent Probe for Bi...

  2026-04-08

  Streptavidin-FITC is a tetrameric fluorescein isothiocyanate conjugated protein with exceptional biotin-binding capacity, enabling ultrasensitive detection of biotinylated molecules in diverse assays. Its robust specificity and high fluorescence output make it the gold standard for protein and nucleic acid labeling in immunohistochemistry, flow cytometry, and nanoparticle trafficking studies.

• Nebivolol Hydrochloride: Selective β1-Adrenoceptor Antago...

  2026-04-07

  Nebivolol hydrochloride is a highly selective β1-adrenoceptor antagonist widely used in cardiovascular pharmacology research. Its sub-nanomolar potency and pathway specificity make it an essential tool for dissecting β1-adrenergic signaling without off-target mTOR effects. This dossier details its mechanism, benchmarks, and experimental integration.

• Oligo (dT) 25 Beads: Precision Magnetic Bead-Based mRNA P...

  2026-04-07

  Oligo (dT) 25 Beads enable rapid, high-specificity magnetic bead-based mRNA purification from eukaryotic samples. This technology supports reliable workflows for RT-PCR, next-generation sequencing, and other molecular biology applications, making it a reference standard for polyA tail mRNA capture.

• PreScission Protease (PSP): Precise HRV 3C Protease for F...

  2026-04-06

  PreScission Protease (PSP) is a recombinant HRV 3C protease engineered for high-specificity fusion protein tag cleavage at the Gln-Gly bond. This protein purification enzyme from APExBIO enables efficient, low-temperature tag removal, supporting recovery of native proteins for molecular biology applications.

• LY2886721: Potent Oral BACE1 Inhibitor for Alzheimer's Di...

  2026-04-06

  LY2886721 is a nanomolar-potency, furothiazine-based oral BACE1 inhibitor for Alzheimer's disease research. It enables robust, dose-dependent amyloid-beta reduction in vitro and in vivo, supporting experimental dissection of the amyloid precursor protein (APP) processing pathway.

• Foretinib (GSK1363089): Mechanistic Insights and Advanced...

  2026-04-05

  Explore the unique multikinase inhibitory mechanisms of Foretinib (GSK1363089) in cancer research. This article delivers a deep scientific analysis of Foretinib’s actions across advanced in vitro and in vivo models, highlighting its impact on tumor growth, cell motility, and metastasis.

• LY2886721: Potent Oral BACE1 Inhibitor for Alzheimer's Di...

  2026-04-04

  LY2886721 is a nanomolar-potency, oral BACE1 inhibitor widely used in Alzheimer's disease research. This compound enables precise amyloid-beta reduction in vitro and in vivo, supporting safe, reproducible studies of amyloid precursor protein processing.

• 5-Methyl-CTP: Bridging Mechanistic RNA Insight and Transl...

  2026-04-03

  This thought-leadership article delivers a strategic deep dive into the use of 5-Methyl-CTP—a 5-methyl modified cytidine triphosphate—as a transformative reagent for in vitro transcription, enhanced mRNA stability, and translational research. Integrating mechanistic perspectives, validation from emerging mRNA vaccine studies, and a forward-looking view, it guides translational researchers to leverage 5-Methyl-CTP for maximal impact in mRNA drug development, gene expression research, and beyond.

14254 records 1/951 page Next 12345 下5页 Last page